Education
About Us
Working with TipRanks
Follow Us
Oxford Nanopore Technologies PLC (GB:ONT)
:ONT
RESEARCH TOOLSreports
ONT Stock Chart & Stats
Day’s Range― - ―
52-Week Range88.60p - 169.20p
Previous CloseN/A
Volume537.27K
Average Volume (3M)4.11M
Market Cap
£1.43B
Enterprise Value1.71B
Total Cash (Recent Filing)£338.37M
Total Debt (Recent Filing)£45.96M
Price to Earnings (P/E)―
Beta1.09
Next Earnings
Sep 02, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding961,065,000
10 Day Avg. Volume1,888,582
30 Day Avg. Volume4,114,920
Financial Highlights & Ratios
PEG Ratio-1.87
Price to Book (P/B)44.45
Price to Sales (P/S)0.00
P/FCF Ratio-61.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£184.00Price Target Upside23.57% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Oxford Nanopore Technologies PLC News
PremiumCompany Announcements
Oxford Nanopore Technologies Releases 2024 Sustainability Report
PremiumCompany Announcements
Oxford Nanopore Expands Share Capital with New Equity Issuance
PremiumCompany Announcements
Oxford Nanopore Sees Increased Stake by EIT Oxford Holdings
PremiumCompany Announcements
Oxford Nanopore Technologies Sees Increase in Major Shareholder Voting RightsPremiumCompany Announcements
Oxford Nanopore Awards Shares to CFO Under Incentive Plan
PremiumCompany Announcements
Oxford Nanopore Sees Change in Major Shareholder Voting Rights
Bulls Say, Bears Say
Bulls Say
Financial StrengthThe company's balance sheet has been strengthened with fresh equity raised from Biomerieux and Novo Holdings.
Market OpportunitiesOxford Nanopore has multiple opportunities to drive long-term revenue growth, with significant potential in the research, clinical, applied industrial, and biopharma markets, and sees proteomics as a potential new frontier.
Product InnovationONT has improved the raw read accuracy of its sequencers to above 99% from around 64%, increased read length capability, and enabled direct RNA sequencing, enhancing its product utility.
Bears Say
Funding EnvironmentThere is a deteriorating funding environment and increasing competition, adding uncertainty to the investment case.
Growth GuidanceThe growth guidance of 20-23% for 2025 is below previous consensus expectations, putting further pressure on the company's growth targets.
Market CompetitionThe entrenched nature of Illumina in the sequencing workflow and increasing competition from companies like Roche present challenges.
Options Prices
Currently, No data available
---
Ownership Overview
2.06% Insiders
3.43%
Mutual Funds
0.01% Other Institutional Investors
90.47% Public Companies and
Individual Investors
ONT FAQ
What was Oxford Nanopore Technologies PLC’s price range in the past 12 months?
Oxford Nanopore Technologies PLC lowest share price was 88.60p and its highest was 169.20p in the past 12 months.
What is Oxford Nanopore Technologies PLC’s market cap?
Oxford Nanopore Technologies PLC’s market cap is £1.43B.
When is Oxford Nanopore Technologies PLC’s upcoming earnings report date?
Oxford Nanopore Technologies PLC’s upcoming earnings report date is Sep 02, 2025 which is in 50 days.
How were Oxford Nanopore Technologies PLC’s earnings last quarter?
Oxford Nanopore Technologies PLC released its earnings results on Mar 04, 2025. The company reported -0.08p earnings per share for the quarter, beating the consensus estimate of -0.1p by 0.02p.
Is Oxford Nanopore Technologies PLC overvalued?
According to Wall Street analysts Oxford Nanopore Technologies PLC’s price is currently Undervalued.
Does Oxford Nanopore Technologies PLC pay dividends?
Oxford Nanopore Technologies PLC does not currently pay dividends.
What is Oxford Nanopore Technologies PLC’s EPS estimate?
Oxford Nanopore Technologies PLC’s EPS estimate is -0.08.
How many shares outstanding does Oxford Nanopore Technologies PLC have?
Oxford Nanopore Technologies PLC has 961,065,000 shares outstanding.
What happened to Oxford Nanopore Technologies PLC’s price movement after its last earnings report?
Oxford Nanopore Technologies PLC reported an EPS of -0.08p in its last earnings report, beating expectations of -0.1p. Following the earnings report the stock price went down -13.13%.
Which hedge fund is a major shareholder of Oxford Nanopore Technologies PLC?
Currently, no hedge funds are holding shares in GB:ONT
Oxford Nanopore Technologies PLC Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
£184.00 (23.57% Upside)
£184.00 (23.57% Upside)
Blogger Sentiment
Bullish
GB:ONT Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth £141.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
40.47%
12-Months-Change
Fundamentals
Return on Equity
-23.77%
Trailing 12-Months
Asset Growth
-3.88%
Trailing 12-Months
Company Description
Oxford Nanopore Technologies PLC
Oxford Nanopore Technologies PLC (ONT) is a biotechnology company that specializes in developing and commercializing nanopore sequencing technology. The company's core product line includes portable and scalable DNA/RNA sequencing devices that facilitate real-time analysis of long DNA or RNA fragments, enabling a variety of applications in genomics research, clinical diagnostics, and environmental analysis. With a focus on innovation, ONT aims to make genetic sequencing more accessible and versatile across different sectors.
ONT Stock 12 Month Forecast
Average Price Target
184.00p
▲(23.57%Upside)
Technical Analysis
Oxford BioMedica
―
Scancell Holdings
―
PureTech Health
―
Avacta Group plc
―
4basebio UK Societas
―